Both in Pharmaceuticals
Biofrontera vs Lipocine
Over the past year BFRI returned −16.4% and LPCN returned −45.1%; their daily moves had a correlation of -0.07.
BFRI −16.4% LPCN −45.1%Growth of $1, one year, split-adjusted
| Metric | BFRI | LPCN |
|---|---|---|
| Price | $0.8864 | $1.51 |
| Market cap | $13.2M | $12.4M |
| Today | +5.55% | +3.42% |
| 1 month | −18.7% | −30.1% |
| 6 months | −19.4% | −34.1% |
| Year to date | +55.5% | −81.2% |
| 1 year | −13.5% | −46.5% |
| Revenue growth (YoY) | +32.9% | −100.0% |
| Gross margin | 79.9% | — |
| Net margin | −5.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.3× | 9.9× |
| Net cash | $47.0K | $23.3M |
| Dividend yield | — | — |
| Volatility (60d) | 74.7% | 56.7% |
| Short % of float | 0.9% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).